Researchers Use Nanoparticles to Test Treatment for Liver Disease

June 25, 2018 | Katie Neith

In an effort to improve options for those with liver cancer, a group of researchers have identified a way of potentially treating a broad range of liver diseases and perhaps even other types of cancer.

Continue Reading

What You Should Know About Multiple Myeloma

March 30, 2018 | Kevin Chesley

Multiple myeloma is a blood cancer involving malignant white blood (plasma) cells in the bone marrow. Most often affecting patients 65 and older, it is a debilitating malignancy.

Meet the CAR T Team: Xiuli Wang, Ph.D.

January 4, 2018 | Maxine Nunes

Xiuli Wang, Ph.D., is at the forefront of one of the most exciting breakthroughs in cancer treatment, chimeric antigen receptor (CAR) T cell therapy.

Simon Bray: Beating the Odds

October 2, 2017 | Abe Rosenberg

Simon Bray had been ignoring a chronic backache for months until one day in the gym, he fractured a vertebra. Puzzled by the unusual workout injury, doctors ran a bunch of tests, which revealed multiple myeloma.

Five Reasons to Become a Bone Marrow Donor

March 24, 2017 | Dory Benford

When Shawn Ahdoot went to donate blood almost 10 years ago, he had no idea that it would change his life forever. Here are five reasons you, too, should become a bone marrow donor.

CAR T Cell Trial for Multiple Myeloma to Launch in 2017

March 22, 2017 | Travis Marshall

CAR T cell therapy research at City of Hope is an innovative and promising approach that recruits the body’s own immune system in the fight against some of the hardest-to-treat cancers, including multiple myeloma.

‘Dwindling’ ribs, failing kidneys: How one woman climbed back from myeloma

March 21, 2017 | Stephanie Smith

Hypercalcemia (high blood calcium), renal problems, anemia and bone problems, also known by the acronym, C.R.A.B. — reflects the typical symptoms of multiple myeloma. City of Hope follows a multiple myeloma patient, Donna McNutt, who finds ways to cope with her diagnosis.

'I had this monster that was in me': Coping with fear of relapse

March 20, 2017 | Stephanie Smith

Relapse is one of the most common fears among cancer patients. Nearly 60 percent of cancer survivors are moderately-to-severely concerned about recurrence one year after remission, according to data from the American Cancer Society. City of Hope follows a multiple myeloma patient, Donna McNutt, who finds ways to cope with her fear and anxiety.

ASH 2016: Groundbreaking new trials show promise for lymphoma and multiple myeloma patients

December 7, 2016 | City of Hope

Numerous clinical trials, which lay the groundwork for novel approaches to lymphoma and multiple myeloma therapies, could ultimately lead to new treatments that improve survival and quality of life for patients with those and other diseases. Additional studies give new insight into best practices for the treatment of various blood cancers.

‘Cancer Fashionista’ dresses up to face myeloma

July 15, 2016 | Stephanie Smith

Appearance and emotions are often intertwined, so it stands to reason that improving what’s going on outwardly could help a patient - at least emotionally - face what’s going on inside with cancer. City of Hope patient Donna McNutt offers tips.